000			02055 a2200517 4500
005			20250517034736.0
264		0	_c20160325
008			201603s 0 0 eng d
022			_a1815-7920
024	7		_a10.5588/ijtld.14.0868 _2doi
040			_aNLM _beng _cNLM
100	1		_aDawson, R
245	0	0	_aTwo-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis. _h[electronic resource]
260			_bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _cJul 2015
300			_a780-6 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAntitubercular Agents _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEthambutol _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIsoniazid _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMycobacterium tuberculosis _xdrug effects
650	0	4	_aPyrazinamide _xtherapeutic use
650	0	4	_aRifampin _xadministration & dosage
650	0	4	_aSouth Africa
650	0	4	_aSputum _xmicrobiology
650	0	4	_aTreatment Outcome
650	0	4	_aTuberculosis, Pulmonary _xdrug therapy
650	0	4	_aYoung Adult
700	1		_aNarunsky, K
700	1		_aCarman, D
700	1		_aGupte, N
700	1		_aWhitelaw, A
700	1		_aEfron, A
700	1		_aBarnes, G L
700	1		_aHoffman, J
700	1		_aChaisson, R E
700	1		_aMcIlleron, H
700	1		_aDorman, S E
773	0		_tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _gvol. 19 _gno. 7 _gp. 780-6
856	4	0	_uhttps://doi.org/10.5588/ijtld.14.0868 _zAvailable from publisher's website
999			_c24964188 _d24964188